Very Low Frequency Heart Rate Variability Predicts the Development of Post-Stroke Infections

  • Dirk BrämerEmail author
  • Albrecht Günther
  • Sven Rupprecht
  • Samuel Nowack
  • Josephine Adam
  • Fenja Meyer
  • Matthias Schwab
  • Ralf Surber
  • Otto W. Witte
  • Heike Hoyer
  • Dirk Hoyer
Original Article


Stroke-induced immunodepression is a major risk factor for severe infectious complications in the immediate post-stroke period. We investigated the predictive value of heart rate variability (HRV) to identify patients at risk of post-stroke infection, systemic inflammatory response syndrome, or severe sepsis during the post-acute interval from days 3 to 5 after stroke onset. A prospective, observational monocentric cohort study was conducted in a university hospital stroke unit of patients with ischemic infarction in the territory of the middle cerebral artery without an ongoing infection at admission. Standard HRV indices were processed from Holter ECG. Recording started within the first day after the onset of stroke. Infection (primary endpoint: pneumonia, urinary tract, unknown localization) was assessed between days 3 and 5. The predictive value of HRV adjusted for clinical data was analyzed by logistic regression models and area under the receiver operating characteristic curve (AUC). From 287 eligible patients, data of 89 patients without event before completion of 24-h Holter ECG were appropriate for prediction of infection (34 events). HRV was significantly associated with incident infection even after adjusting for clinical covariates. Very low frequency (VLF) band power adjusted for both, the National Institutes of Health Stroke Scale (NIHSS) at admission and diabetes predicted infection with AUC = 0.80 (cross-validation AUC = 0.74). A model with clinical data (diabetes, NIHSS at admission, involvement of the insular cortex) performed similarly well (AUC = 0.78, cross-validation AUC = 0.71). Very low frequency HRV, an index of integrative autonomic-humoral control, predicts the development of infectious complications in the immediate post-stroke period. However, the additional predictive value of VLF band power over clinical risk factors such as stroke severity and insular involvement was marginal. The continuous HRV monitoring starting immediately after admission might probably increase the predictive performance of VLF band power. That needs to be clarified in further investigations.


Stroke Infection Pneumonia Autonomic nervous system Immune system Heart rate variability PRED-SEP 



We thank Cornelia Eichhorn of the Center for Clinical Studies, Jena University Hospital, for the data management and Nasim Kroegel for carefully editing the manuscript.

Funding Information

The work was funded by the Federal Ministry of Education and Research (BMBF), Germany (FKZ: 01EO1002).

Compliance with Ethical Standards

The study protocol was approved by the local ethic committee of the Jena University Hospital and registered at the German Clinical Trial Register DRKS00003392. Each patient gave written informed consent.

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 2008;3:e2158.CrossRefGoogle Scholar
  2. 2.
    Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–18.CrossRefGoogle Scholar
  3. 3.
    Heikinheimo T, Broman J, Haapaniemi E, Kaste M, Tatlisumak T, Putaala J. Preceding and poststroke infections in young adults with first-ever ischemic stroke: effect on short-term and long-term outcomes. Stroke. 2013;44:3331–7.CrossRefGoogle Scholar
  4. 4.
    Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110.CrossRefGoogle Scholar
  5. 5.
    Diener HC, Weimar C. Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme; 2012.Google Scholar
  6. 6.
    Westendorp WF, Vermeij JD, Vermeij F, Den Hertog HM, DWJ D, van de Beek D, et al. Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Db Syst Rev. 2012;1:CD008530.Google Scholar
  7. 7.
    Wartenberg KE, Stoll A, Funk A, Meyer A, Schmidt JM, Berrouschot J. Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat. 2011;2011:830614.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Hoffmann S, Malzahn U, Harms H, Koennecke HC, Berger K, Kalic M, et al. Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke. 2012;43:2617–23.CrossRefGoogle Scholar
  9. 9.
    Hoffmann S, Harms H, Ulm L, Nabavi DG, Mackert BM, Schmehl I, et al. Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia—the PREDICT study. J Cereb Blood Flow Metab. 2016:271678X16671964.Google Scholar
  10. 10.
    Harms H, Grittner U, Droge H, Meisel A. Predicting post-stroke pneumonia: the PANTHERIS score. Acta Neurol Scand. 2013;128:178–84.CrossRefGoogle Scholar
  11. 11.
    Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775–86.CrossRefGoogle Scholar
  12. 12.
    Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38:770–3.CrossRefGoogle Scholar
  13. 13.
    Benarroch EE. Autonomic-mediated immunomodulation and potential clinical relevance. Neurology. 2009;73:236–42.CrossRefGoogle Scholar
  14. 14.
    Colivicchi F, Bassi A, Santini M, Caltagirone C. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke. 2004;35:2094–8.CrossRefGoogle Scholar
  15. 15.
    Lanza GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, Ciriello G, et al. Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina. Heart. 2006;92:1055–63.CrossRefGoogle Scholar
  16. 16.
    Stein PK, Barzilay JI, Chaves PH, Mistretta SQ, Domitrovich PP, Gottdiener JS, et al. Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the Cardiovascular Health Study (CHS). J Cardiovasc Electrophysiol. 2008;19:1169–74.CrossRefGoogle Scholar
  17. 17.
    Frasure-Smith N, Lesperance F, Irwin MR, Talajic M, Pollock BG. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun. 2009;23:1140–7.CrossRefGoogle Scholar
  18. 18.
    Kop WJ, Stein PK, Tracy RP, Barzilay JI, Schulz R, Gottdiener JS. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med. 2010;72:626–35.CrossRefGoogle Scholar
  19. 19.
    von Kanel R, Carney RM, Zhao S, Whooley MA. Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study. Clin Res Cardiol. 2011;100:241–7.CrossRefGoogle Scholar
  20. 20.
    Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res. 2012;2012:878760.CrossRefGoogle Scholar
  21. 21.
    Young LC, Roediger MP, Grandits G, Baker J, Somboonwit C, Williams I, et al. Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals. Biomark Med. 2014;8:1073–83.CrossRefGoogle Scholar
  22. 22.
    Cooper TM, McKinley PS, Seeman TE, Choo TH, Lee S, Sloan RP. Heart rate variability predicts levels of inflammatory markers: evidence for the vagal anti-inflammatory pathway. Brain Behav Immun. 2015;49:94–100.CrossRefGoogle Scholar
  23. 23.
    Saito I, Hitsumoto S, Maruyama K, Eguchi E, Kato T, Okamoto A, et al. Impact of heart rate variability on C-reactive protein concentrations in Japanese adult nonsmokers: the Toon Health Study. Atherosclerosis. 2016;244:79–85.CrossRefGoogle Scholar
  24. 24.
    Griffin MP, O’Shea TM, Bissonette EA, Harrell FE Jr, Lake DE, Moorman JR. Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res. 2003;53:920–6.CrossRefGoogle Scholar
  25. 25.
    Schmidt JM, Sow D, Crimmins M, Albers D, Agarwal S, Claassen J, et al. Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage. Neurocrit Care. 2014;20:382–9.CrossRefGoogle Scholar
  26. 26.
    Günther A, Salzmann I, Nowack S, Schwab M, Surber R, Hoyer H, et al. Heart rate variability—a potential early marker of sub-acute post-stroke infections. Acta Neurol Scand. 2012;126:189–96.CrossRefGoogle Scholar
  27. 27.
    Brämer D, Hoyer H, Gunther A, Nowack S, Brunkhorst FM, Witte OW, et al. Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurol. 2014;14:9.CrossRefGoogle Scholar
  28. 28.
    TaskForce. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043–65.CrossRefGoogle Scholar
  29. 29.
    Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci. 2010;8:Doc14.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.CrossRefGoogle Scholar
  31. 31.
    Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T, et al. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock. 2007;28:549–53.CrossRefGoogle Scholar
  32. 32.
    Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med. 2007;13:178–84.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Stein PK, Barzilay JI, Chaves PH, Traber J, Domitrovich PP, Heckbert SR, et al. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J Am Geriatr Soc. 2008;56:315–21.CrossRefGoogle Scholar
  34. 34.
    Fairchild KD, Srinivasan V, Moorman JR, Gaykema RP, Goehler LE. Pathogen-induced heart rate changes associated with cholinergic nervous system activation. Am J Phys Regul Integr Comp Phys. 2011;300:R330–R9.Google Scholar
  35. 35.
    Stein PK, Schmieg RE Jr, El-Fouly A, Domitrovich PP, Buchman TG. Association between heart rate variability recorded on postoperative day 1 and length of stay in abdominal aortic surgery patients. Crit Care Med. 2001;29:1738–43.CrossRefGoogle Scholar
  36. 36.
    Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10:88–101.CrossRefGoogle Scholar
  37. 37.
    Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 1996;24:1107–16.CrossRefGoogle Scholar
  38. 38.
    Schmidt H, Muller-Werdan U, Hoffmann T, Francis DP, Piepoli MF, Rauchhaus M, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005;33:1994–2002.CrossRefGoogle Scholar
  39. 39.
    Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29–35.CrossRefGoogle Scholar
  40. 40.
    Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008;7:341–53.CrossRefGoogle Scholar
  41. 41.
    Walter U, Kolbaske S, Patejdl R, Steinhagen V, Abu-Mugheisib M, Grossmann A, et al. Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol. 2013;20:153–9.CrossRefGoogle Scholar
  42. 42.
    Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R, Meisel C, et al. Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis. 2011;32:552–60.CrossRefGoogle Scholar
  43. 43.
    Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS, et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 2009;87:266–74.CrossRefGoogle Scholar
  44. 44.
    Hoyer D, Frank B, Baranowski R, Zebrowski JJ, Stein PK, Schmidt H. Autonomic information flow rhythms. From heart beat interval to circadian variation. IEEE Eng Med Biol Mag. 2007;26:19–24.CrossRefGoogle Scholar
  45. 45.
    Alamili M, Rosenberg J, Gogenur I. Day-night variation in heart rate variability changes induced by endotoxaemia in healthy volunteers. Acta Anaesthesiol Scand. 2015;59:457–64.CrossRefGoogle Scholar
  46. 46.
    Rahman SA, Castanon-Cervantes O, Scheer FA, Shea SA, Czeisler CA, Davidson AJ, et al. Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans. Brain Behav Immun. 2015;47:4–13.CrossRefGoogle Scholar
  47. 47.
    Yaniv Y, Lakatta EG. The end effector of circadian heart rate variation: the sinoatrial node pacemaker cell. BMB Rep. 2015;48:677–84.CrossRefGoogle Scholar
  48. 48.
    Stein PK. Challenges of heart rate variability research in the ICU. Crit Care Med. 2013;41:666–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Dirk Brämer
    • 1
    • 2
    Email author
  • Albrecht Günther
    • 1
  • Sven Rupprecht
    • 1
  • Samuel Nowack
    • 1
    • 2
  • Josephine Adam
    • 1
  • Fenja Meyer
    • 1
  • Matthias Schwab
    • 1
  • Ralf Surber
    • 3
  • Otto W. Witte
    • 1
  • Heike Hoyer
    • 4
  • Dirk Hoyer
    • 1
  1. 1.Hans Berger Department of NeurologyJena University HospitalJenaGermany
  2. 2.Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC)Jena University HospitalJenaGermany
  3. 3.Department of Internal Medicine, Division of CardiologyJena University HospitalJenaGermany
  4. 4.Institute of Medical Statistics, Computer and Data SciencesJena University HospitalJenaGermany

Personalised recommendations